xylazine has been researched along with 3-cyclopentyloxy-4-methoxybenzaldehyde in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Argellati, F; Balbi, A; Bollen, E; Brullo, C; Bruno, O; Canepa, E; Cavallero, A; Domenicotti, C; Erb, K; Fedele, E; Gardella, E; Gijselaers, HJ; Limebeer, CL; Marinari, UM; Parker, LA; Prickaerts, J; Pronzato, MA; Ricciarelli, R; Vanmierlo, T | 1 |
1 other study(ies) available for xylazine and 3-cyclopentyloxy-4-methoxybenzaldehyde
Article | Year |
---|---|
GEBR-7b, a novel PDE4D selective inhibitor that improves memory in rodents at non-emetic doses.
Topics: Animals; Cyclic AMP; Cyclic Nucleotide Phosphodiesterases, Type 4; Dose-Response Relationship, Drug; Enzyme-Linked Immunosorbent Assay; Hippocampus; Imines; Ketamine; Male; Memory; Mice; Mice, Inbred C57BL; Morpholines; Phosphodiesterase Inhibitors; Rats; Rats, Sprague-Dawley; Rats, Wistar; Xylazine | 2011 |